Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.

NCT00474864 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Dyslipidaemias
Dyslipidaemia

Interventions

DRUG: GW856553

Sponsor

GlaxoSmithKline